OptiNOs, our clinically tested nitric oxide booster & muscle builder, turns on pathways in our body that signal the production of nitric oxide and protein synthesis
A 2022 survey conducted via an online peptide-user community (N=312 self-reported users) found that 68% cited tendon or ligament injury as their primary indication, 21% cited muscle strain, and 11% cited GI conditions such as leaky gut or IBD-related symptoms
Post-Injection Guidance Your provider discusses any follow-up recommendations, including the suggested frequency for ongoing injections based on your individual needs and goals
After 12 weeks, you can increase the dosage if needed
Results vary widely, but many individuals notice improved glow, clarity, and overall wellness with consistent sessions
In five long COVID patients dACC data were not obtained